每年用药2次!吉利德HIV新药Sunlenca(lenacapavir)获FDA批准上市(ZT)

https://www.163.com/dy/article/HP9DA1GG0553TJWI.html

https://www.businesswire.com/news/home/20221221005541/en/Sunlenca%C2%AE-lenacapavir-Receives-FDA-Approval-as-a-First-in-Class-Twice-Yearly-Treatment-Option-for-People-Living-With-Multi-Drug-Resistant-HIV

估计乙肝治疗新药也快被它家突破了.

所有跟帖： 

• 只是有点贵，“Sunlenca注射液和片剂预计在治疗的第一年将花费42,250美元，之后每年将花费39,000美元” -zillos- ♂ (0 bytes) () 12/23/2022 postreply 15:56:43

• 保险不包吗？ -桃花好运- ♀ (0 bytes) () 12/23/2022 postreply 16:32:55